This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
About the report
This report explores the essential role that care pathways play in delivering best-practice lung cancer care.
Despite evidence showing that high-quality care pathways can improve survival and outcomes, only a small number of countries and regions have established formal care pathways for lung cancer. It is important to build on this initial progress and underscore the value of care pathways to inspire future pathway development.
The report was informed by a comprehensive review of the literature and consultation with experts from across the world. It recommends actions to optimise high-quality care pathways for lung cancer, including: ensuring multidisciplinary care throughout the pathway, determining clear, time-defined targets for different stages of lung cancer care, and readily incorporating new biomarkers and targeted treatments into care pathways for lung cancer.
It is our hope that this report and its recommendations support health system leaders and decision-makers in delivering high-quality care through implementation of effective, consensus-driven care pathways for lung cancer.
'Care pathways have the potential to revolutionise healthcare. Every care pathway must be thoughtfully developed and organised, and informed by the latest evidence and guidelines. This way, when implemented, it will have maximal impact.'
PROFESSOR ROBERT THOMAS, UNIVERSITY OF MELBOURNE, AUSTRALIA